Search research articles
Contact Us
Filters
Showing results (1-10 of 124) with videos related to
Page
of 13
Sort By:
Expert Review of Clinical Immunology
|
May 19, 2010
Chronic urticaria: assessment of current treatment
Bettina Wedi, Alexander Kapp
Clinical Drug Investigation
|
December 14, 2006
Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trials
Alexander Kapp, Nadia Demarteau
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
June 30, 2006
[Neurodermatitis]
Alexander Kapp, Thomas Werfel
American Journal of Clinical Dermatology
|
May 16, 2002
Helicobacter pylori infection in skin diseases: a critical appraisal
Bettina Wedi, Alexander Kapp
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 7, 2006
[Specific immunotherapy]
Alexander Kapp, Bettina Wedi
Krankenpflege Journal
|
January 7, 2004
[19th Progress in Allergology, Immunology and Dermatology Congress in Davos. Chronic urticaria treatable in a large percentage of cases]
Alexander Kapp, Bettina Wedi
Current Opinion in Allergy and Clinical Immunology
|
September 1, 2005
Neuroimmunological findings in allergic skin diseases
Ulrike Raap, Alexander Kapp
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
February 6, 2007
Evidence-based therapy of chronic urticaria
Bettina Wedi, Alexander Kapp
International Journal of Dermatology
|
May 3, 2006
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study
Alexander Kapp, Werner J Pichler
Allergy
|
February 1, 2020
The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function
Bettina Wedi, Manuela Gehring, Alexander Kapp
Page
of 13
Search research articles
Search
Showing results (1-10 of 124) with videos related to
Sort By:
Page
of 13
Expert Review of Clinical Immunology
|
May 19, 2010
Chronic urticaria: assessment of current treatment
Bettina Wedi, Alexander Kapp
Clinical Drug Investigation
|
December 14, 2006
Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trials
Alexander Kapp, Nadia Demarteau
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
June 30, 2006
[Neurodermatitis]
Alexander Kapp, Thomas Werfel
American Journal of Clinical Dermatology
|
May 16, 2002
Helicobacter pylori infection in skin diseases: a critical appraisal
Bettina Wedi, Alexander Kapp
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 7, 2006
[Specific immunotherapy]
Alexander Kapp, Bettina Wedi
Krankenpflege Journal
|
January 7, 2004
[19th Progress in Allergology, Immunology and Dermatology Congress in Davos. Chronic urticaria treatable in a large percentage of cases]
Alexander Kapp, Bettina Wedi
Current Opinion in Allergy and Clinical Immunology
|
September 1, 2005
Neuroimmunological findings in allergic skin diseases
Ulrike Raap, Alexander Kapp
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
February 6, 2007
Evidence-based therapy of chronic urticaria
Bettina Wedi, Alexander Kapp
International Journal of Dermatology
|
May 3, 2006
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study
Alexander Kapp, Werner J Pichler
Allergy
|
February 1, 2020
The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function
Bettina Wedi, Manuela Gehring, Alexander Kapp
Page
of 13